Great or terrible place to work depending on where and for whom: opiniones de empleados con el puesto de Director en Merck

3,0
5 ene 2019
Recomendar
Aprobación del CEO
Perspectiva de la empresa

Ventajas

Great near term growth thanks to Keytruda, ability to learn a lot on the job, facilities outside of PA/NJ can be good to work for if you happen to be at a facility with a dynamic plant manager, benefits are very good, some good decisions on acquisitions have been made, line employees generally well trained and care about doing a good job.

Desventajas

Can be uptight and hierarchal, refuse to prioritize in some areas despite calls from CEO to do so, leading to confusion about how to get EVERYTHING done, some openly unethical senior managers that are allowed to remain in role, culture of punishment versus learning from mistakes, very old school style of management with diversity and inclusion “bolted on”, creating and obvious but weak effort to try to be an employer of choice, haven’t figured out how to retain millennials mostly because senior leadership won’t take advice from experts.

Echa un vistazo a otras opiniones sobre Merck.

5,0
30 jun 2026
Recomendar
Aprobación del CEO
Perspectiva de la empresa

Ventajas

Excellent company to work with.

Desventajas

No cons encountered so far

4,0
30 jun 2026
Recomendar
Aprobación del CEO
Perspectiva de la empresa

Ventajas

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Desventajas

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Ver opiniones por: Útil|Valoración|Fecha|Todo